Literature DB >> 15619074

Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice.

A G S van Halteren1, M J Kardol, A Mulder, B O Roep.   

Abstract

AIMS/HYPOTHESIS: An important prerequisite for the initiation of pancreatic islet inflammation is the recruitment of pathogenic T cells. We investigated the in vivo migration patterns of human islet-reactive T cell clones after transfer into compromised hosts.
METHODS: NOD-scid mice were injected with a mixture of human autoreactive T cells and antigen-presenting cells. Survival and migration of T cells was analysed by fluorescence-activated cell sorter and immunohistochemical analysis of various tissues.
RESULTS: Autoreactive T cells and antigen-presenting cells survived at least 14 days in vivo and accumulated in spleen, pancreatic tissue and pancreas draining lymph nodes, but not elsewhere, as early as 4 days after transfer. This homing was dependent on co-injection of human antigen-presenting cells loaded with autoantigen. Finally, we found that this process is enhanced by streptozotocin treatment. Streptozotocin treatment did not affect the constitutive homing to pancreas draining lymph nodes. Histological analysis of pancreatic tissue sections showed some autoreactive T cells around the islets of Langerhans, comparable to early peri-islet insulitis. However, the majority of pancreas-infiltrating T cells accumulated around blood vessels in the exocrine pancreas. All T cell clones expressed the chemokine receptor CXCR3 that is associated with homing to insulitic lesions in men and mice. CONCLUSIONS/
INTERPRETATION: Our study provides the first evidence of in vivo accumulation in pancreatic tissue of islet-reactive T cells derived from type 1 diabetic patients. The fact that such T cells do not penetrate islets is in line with the concept that additional factors may be required for the entry of T cells into inflamed islets to become diabetogenic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619074     DOI: 10.1007/s00125-004-1613-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.

Authors:  James E Greening; Timothy I M Tree; Karolena T Kotowicz; Astrid G van Halteren; Bart O Roep; Nigel J Klein; Mark Peakman
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

2.  Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration.

Authors:  D M Leppink; D K Bishop; D D Sedmak; M L Henry; R M Ferguson; P R Streeter; E C Butcher; C G Orosz
Journal:  Transplantation       Date:  1989-11       Impact factor: 4.939

Review 3.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

4.  The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

Authors:  L Piali; C Weber; G LaRosa; C R Mackay; T A Springer; I Clark-Lewis; B Moser
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

5.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

6.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

7.  Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.

Authors:  Urs Christen; Dorian B McGavern; Andrew D Luster; Matthias G von Herrath; Michael B A Oldstone
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

8.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

9.  Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

Authors:  M G von Herrath; M B Oldstone
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  14 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

2.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

3.  The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.

Authors:  E Aboumrad; A M Madec; C Thivolet
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

4.  Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.

Authors:  Wilhem Leconet; Pierre Petit; Sylvie Peraldi-Roux; Damien Bresson
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

Review 5.  Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Authors:  Michael A Brehm; Alvin C Powers; Leonard D Shultz; Dale L Greiner
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  Islet inflammation and CXCL10 in recent-onset type 1 diabetes.

Authors:  B O Roep; F S Kleijwegt; A G S van Halteren; V Bonato; U Boggi; F Vendrame; P Marchetti; F Dotta
Journal:  Clin Exp Immunol       Date:  2010-01-05       Impact factor: 4.330

7.  The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice.

Authors:  M Hultcrantz; S Jacobson; N J Hill; P Santamaria; M Flodström-Tullberg
Journal:  Diabetologia       Date:  2008-11-25       Impact factor: 10.122

Review 8.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.

Authors:  James A Pearson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2015-09-26       Impact factor: 7.094

Review 9.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330

10.  Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.

Authors:  Wendy W J Unger; Todd Pearson; Joana R F Abreu; Sandra Laban; Arno R van der Slik; Sacha Mulder-van der Kracht; Michel G D Kester; Dave V Serreze; Leonard D Shultz; Marieke Griffioen; Jan Wouter Drijfhout; Dale L Greiner; Bart O Roep
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.